Gut microbiota in colorectal cancer development and therapy

被引:378
作者
Wong, Chi Chun
Yu, Jun [1 ]
机构
[1] Chinese Univ Hong Kong, Inst Digest Dis, Hong Kong, Peoples R China
关键词
NF-KAPPA-B; LACTOBACILLUS-RHAMNOSUS-GG; NUCLEATUM PROMOTES CHEMORESISTANCE; ANTIBIOTIC-ASSOCIATED DIARRHEA; INTESTINAL EPITHELIAL-CELLS; INHIBITS COLON-CANCER; LACTIC-ACID BACTERIA; FUSOBACTERIUM-NUCLEATUM; DIETARY FIBER; BILE-ACID;
D O I
10.1038/s41571-023-00766-x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Emerging data indicate a central role for the microbiota in all aspects of colorectal cancer (CRC). Despite this general consensus, understanding the role of specific components of the microbiota in such a way that enables the development of clinical interventions or tools to inform clinical decision-making has thus far proved challenging. In this Review, the authors summarize the role of the microbiota in CRC, including in prevention, in interactions with treatment and as a source of novel biomarkers. Colorectal cancer (CRC) is one of the commonest cancers globally. A unique aspect of CRC is its intimate association with the gut microbiota, which forms an essential part of the tumour microenvironment. Research over the past decade has established that dysbiosis of gut bacteria, fungi, viruses and Archaea accompanies colorectal tumorigenesis, and these changes might be causative. Data from mechanistic studies demonstrate the ability of the gut microbiota to interact with the colonic epithelia and immune cells of the host via the release of a diverse range of metabolites, proteins and macromolecules that regulate CRC development. Preclinical and some clinical evidence also underscores the role of the gut microbiota in modifying the therapeutic responses of patients with CRC to chemotherapy and immunotherapy. Herein, we summarize our current understanding of the role of gut microbiota in CRC and outline the potential translational and clinical implications for CRC diagnosis, prevention and treatment. Emphasis is placed on how the gut microbiota could now be better harnessed by developing targeted microbial therapeutics as chemopreventive agents against colorectal tumorigenesis, as adjuvants for chemotherapy and immunotherapy to boost drug efficacy and safety, and as non-invasive biomarkers for CRC screening and patient stratification. Finally, we highlight the hurdles and potential solutions to translating our knowledge of the gut microbiota into clinical practice.
引用
收藏
页码:429 / 452
页数:24
相关论文
共 399 条
[1]   Fap2 Mediates Fusobacterium nucleatum Colorectal Adenocarcinoma Enrichment by Binding to Tumor-Expressed Gal-GalNAc [J].
Abed, Jawad ;
Emgard, Johanna E. M. ;
Zamir, Gideon ;
Faroja, Mouhammad ;
Almogy, Gideon ;
Grenov, Amalie ;
Sol, Asaf ;
Naor, Ronit ;
Pikarsky, Eli ;
Atlan, Karine A. ;
Mellul, Anna ;
Chaushu, Stella ;
Manson, Abigail L. ;
Earl, Ashlee M. ;
Ou, Nora ;
Brennan, Caitlin A. ;
Garrett, Wendy S. ;
Bachrach, Gilad .
CELL HOST & MICROBE, 2016, 20 (02) :215-225
[2]   The apoptotic impact of nisin as a potent bacteriocin on the colon cancer cells [J].
Ahmadi, Shiva ;
Ghollasi, Marzieh ;
Hosseini, Hamideh Mahmoodzadeh .
MICROBIAL PATHOGENESIS, 2017, 111 :193-197
[3]   Human Gut Microbiome and Risk for Colorectal Cancer [J].
Ahn, Jiyoung ;
Sinha, Rashmi ;
Pei, Zhiheng ;
Dominianni, Christine ;
Wu, Jing ;
Shi, Jianxin ;
Goedert, James J. ;
Hayes, Richard B. ;
Yang, Liying .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2013, 105 (24) :1907-1911
[4]   Generating somatic mosaicism with a Cre recombinase - microsatellite sequence transgene [J].
Akyol, Aytekin ;
Hinoi, Takao ;
Feng, Ying ;
Bommer, Guido T. ;
Glaser, Thomas M. ;
Fearon, Eric R. .
NATURE METHODS, 2008, 5 (03) :231-233
[5]   A unified catalog of 204,938 reference genomes from the human gut microbiome [J].
Almeida, Alexandre ;
Nayfach, Stephen ;
Boland, Miguel ;
Strozzi, Francesco ;
Beracochea, Martin ;
Shi, Zhou Jason ;
Pollard, Katherine S. ;
Sakharova, Ekaterina ;
Parks, Donovan H. ;
Hugenholtz, Philip ;
Segata, Nicola ;
Kyrpides, Nikos C. ;
Finn, Robert D. .
NATURE BIOTECHNOLOGY, 2021, 39 (01) :105-114
[6]   Extracellular vesicles derived from Lactobacillus plantarum restore chemosensitivity through the PDK2-mediated glucose metabolic pathway in 5-FU-resistant colorectal cancer cells [J].
An, JaeJin ;
Ha, Eun-Mi .
JOURNAL OF MICROBIOLOGY, 2022, 60 (07) :735-745
[7]   GABA-producing Lactobacillus plantarum inhibits metastatic properties and induces apoptosis of 5-FU-resistant colorectal cancer cells via GABAB receptor signaling [J].
An, JaeJin ;
Seok, Heon ;
Ha, Eun-Mi .
JOURNAL OF MICROBIOLOGY, 2021, 59 (02) :202-216
[8]   Lactobacillus-derived metabolites enhance the antitumor activity of 5-FU and inhibit metastatic behavior in 5-FU-resistant colorectal cancer cells by regulating claudin-1 expression [J].
An, JaeJin ;
Ha, Eun-Mi .
JOURNAL OF MICROBIOLOGY, 2020, 58 (11) :967-977
[9]  
An J, 2016, J MICROBIOL BIOTECHN, V26, P1490
[10]   Fungal microbiome in colorectal cancer: a systematic review [J].
Anandakumar, Arun ;
Pellino, Gianluca ;
Tekkis, Paris ;
Kontovounisios, Christos .
UPDATES IN SURGERY, 2019, 71 (04) :625-630